Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (Aim 2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02461628|
Recruitment Status : Completed
First Posted : June 3, 2015
Results First Posted : October 29, 2019
Last Update Posted : October 29, 2019
|Condition or disease||Intervention/treatment||Phase|
|Fever Malaria||Behavioral: Malaria RDT & conditional voucher for ACT from retail sector||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40340 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Innovative Partnership to Target Antimalarial Subsidies in the Retail Sector|
|Study Start Date :||July 2015|
|Actual Primary Completion Date :||May 26, 2017|
|Actual Study Completion Date :||July 12, 2017|
Experimental: Malaria RDT & conditional voucher
In the intervention arm, trained community health volunteers (CHVs) will offer eligible household members a free malaria rapid diagnostic test (RDT) and a voucher allowing the purchase of a qualified artemisinin combination therapy (ACT) at a reduced fixed price in the retail sector conditional on a positive test.
Behavioral: Malaria RDT & conditional voucher for ACT from retail sector
Trained community health volunteers will offer eligible household members free malaria rapid diagnostic tests and a voucher allowing the purchase of a qualified ACT at a reduced fixed price in the retail sector conditional on a positive test
No Intervention: Comparison Arm
Individuals in the comparison arm will only receive standard community health volunteer (CHV) visits.
- Number of Subjects With a Fever Who Receive a Malaria Test From Any Source [ Time Frame: 6 months, 12 months, 18 months ]
- Number of Participants Using ACT Who Had a Positive Test [ Time Frame: 6 months, 12 months, 18 months ]
- Number of Participants Using an ACT Who Did Not Have a Test [ Time Frame: 6 months, 12 months, 18 months ]
- Number of Subjects Who Received a Correct Dose of AL (Artemether Lumefantrine) [ Time Frame: 6 months, 12 months, 18 months ]Denominator is all those who took AL. Artemether lumefantrine is one type of ACT.
- Number of Subjects With Fever That Received Correct Treatment [ Time Frame: 6 months, 12 months, 18 months ]The number of people with fever that report receiving correct treatment with regards to malaria (i.e., received an RDT test and took ACTs if the result was positive, or did not take ACTs if the test result was negative).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02461628
|Principal Investigator:||Wendy O'Meara, PhD||Duke University|